Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| goblet cell | 9 studies | 57% ± 13% | |
| ionocyte | 5 studies | 64% ± 8% | |
| renal alpha-intercalated cell | 5 studies | 51% ± 6% | |
| brush cell | 5 studies | 52% ± 19% | |
| renal beta-intercalated cell | 4 studies | 56% ± 27% | |
| enteroendocrine cell | 4 studies | 42% ± 15% |
Insufficient scRNA-seq data for expression of HEPACAM2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 96% | 130.03 | 316 / 328 | 63% | 30.55 | 113 / 178 |
| intestine | 67% | 1421.53 | 643 / 966 | 64% | 27.87 | 335 / 527 |
| stomach | 75% | 163.25 | 270 / 359 | 49% | 16.65 | 141 / 286 |
| kidney | 100% | 877.94 | 89 / 89 | 11% | 28.71 | 97 / 901 |
| breast | 56% | 134.56 | 256 / 459 | 40% | 6.54 | 449 / 1118 |
| prostate | 48% | 27.23 | 118 / 245 | 45% | 3.64 | 228 / 502 |
| peripheral blood | 51% | 44.49 | 473 / 929 | 0% | 0 | 0 / 0 |
| bladder | 14% | 5.90 | 3 / 21 | 26% | 8.35 | 130 / 504 |
| esophagus | 3% | 1.91 | 41 / 1445 | 27% | 10.27 | 50 / 183 |
| lung | 6% | 2.12 | 34 / 578 | 17% | 6.10 | 198 / 1155 |
| spleen | 16% | 9.58 | 38 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 5% | 1.56 | 12 / 258 | 10% | 0.97 | 23 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 2.65 | 3 / 29 |
| uterus | 1% | 0.27 | 2 / 170 | 6% | 0.77 | 27 / 459 |
| brain | 5% | 1.95 | 144 / 2642 | 1% | 0.07 | 7 / 705 |
| thymus | 1% | 0.27 | 4 / 653 | 4% | 1.48 | 23 / 605 |
| liver | 0% | 0.12 | 1 / 226 | 2% | 0.22 | 10 / 406 |
| skin | 2% | 0.71 | 41 / 1809 | 0% | 0.04 | 1 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.23 | 1 / 45 |
| ovary | 0% | 0 | 0 / 180 | 1% | 0.09 | 4 / 430 |
| adipose | 0% | 0.20 | 5 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.09 | 4 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.03 | 1 / 803 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.08 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051301 | Biological process | cell division |
| GO_0007098 | Biological process | centrosome cycle |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005813 | Cellular component | centrosome |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0030496 | Cellular component | midbody |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0072686 | Cellular component | mitotic spindle |
| GO_0005819 | Cellular component | spindle |
| GO_0005515 | Molecular function | protein binding |
| Gene name | HEPACAM2 |
| Protein name | Alternative protein HEPACAM2 HEPACAM family member 2 (Mitotic kinetics regulator) HEPACAM family member 2 |
| Synonyms | MIKI UNQ305/PRO346 |
| Description | FUNCTION: Required during prometaphase for centrosome maturation. Following poly-ADP-ribosylation (PARsylation) by TNKS, translocates from the Golgi apparatus to mitotic centrosomes and plays a key role in the formation of robust microtubules for prompt movement of chromosomes: anchors AKAP9/CG-NAP, a scaffold protein of the gamma-tubulin ring complex and promotes centrosome maturation. . |
| Accessions | ENST00000341723.8 [A8MVW5-2] ENST00000453812.2 [A8MVW5-3] A8MVW5 ENST00000394468.7 [A8MVW5-1] ENST00000440868.5 C9JN07 L8EC70 |
